Aparajita Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aparajita Das has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Sarbani Giri
Assam University, Silchar, India
2 shared publications - Anirudha Giri
Assam University
1 shared publication - Dharmeswar Barhoi
Assam University, Silchar, India
1 shared publication - Doli Talukdar
Molecular and Cell Biology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar, 788011, India
1 shared publication - Neelam Pandey
Molecular and Cell Biology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar, 788011, India
1 shared publication - Pimily Langthasa
Molecular and Cell Biology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar, 788011, India
1 shared publication
Latest Publications
- Open Access
- 31 July 2024
- Published by IntechOpen
Role of Reactive Oxygen Species in Carcinogenesis and Polyphenols as an Emerging Therapeutic Intervention
Reactive oxygen species (ROS) are generated in the body as a by-product of cellular enzymatic reactions. Under normal conditions, an antioxidant defense mechanism in the body regulates the level of ROS produced and maintains a redox balance. However, in cases of metabolic disorder, chronic inflammation, or prolonged exposure to xenobiotics and environmental stressors, this balance is disturbed and leads to the generation of oxidative stress. ROS can attack the structural integrity of the major macromolecules of the body such as nucleic acids, lipids, and proteins leading to the generation of pathologies including cancer. Polyphenols have emerged as potent nutraceuticals that can not only augment the body’s antioxidant defense system to combat the generated oxidative stress but can also selectively act as pro-oxidants in cancer cells, a dichotomous phenomenon that is being actively studied for implementation in cancer therapeutics. This chapter will present in a comprehensive manner the role of ROS in the pathogenesis of cancer and the application of pro-oxidant nature of polyphenols as chemotherapeutics.
- 31 July 2024
- Published by IntechOpen
Open AccessRole of Reactive Oxygen Species in Carcinogenesis and Polyphenols as an Emerging Therapeutic Intervention
Reactive oxygen species (ROS) are generated in the body as a by-product of cellular enzymatic reactions. Under normal conditions, an antioxidant defense mechanism in the body regulates the level of ROS produced and maintains a redox balance. However, in cases of metabolic disorder, chronic inflammation, or prolonged exposure to xenobiotics and environmental stressors, this balance is disturbed and leads to the generation of oxidative stress. ROS can attack the structural integrity of the major macromolecules of the body such as nucleic acids, lipids, and proteins leading to the generation of pathologies including cancer. Polyphenols have emerged as potent nutraceuticals that can not only augment the body’s antioxidant defense system to combat the generated oxidative stress but can also selectively act as pro-oxidants in cancer cells, a dichotomous phenomenon that is being actively studied for implementation in cancer therapeutics. This chapter will present in a comprehensive manner the role of ROS in the pathogenesis of cancer and the application of pro-oxidant nature of polyphenols as chemotherapeutics.